Federica Sommonte

Mrs. Federica Sommonte

Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Bari, Puglia, Italy
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Federica SommonteFederica Sommonte
Federica Sommonte
Nunzio DenoraNunzio Denora
Nunzio Denora
Dimitrios A. LamprouDimitrios A. Lamprou
Dimitrios A. Lamprou
Nanomedicine has grown tremendously in recent years as a responsive strategy to find novel therapies for treating challenging pathological conditions. As a result, there is an urgent need to develop novel formulations capable of providing adequate therapeutic treatment while overcoming the limitations of traditional protocols. Lately, microfluidic technology (MF) and additive manufacturing (AM) have both acquired popularity, bringing numerous benefits to a wide range of life science applications. There have been numerous benefits and drawbacks of MF and AM as distinct techniques, with case studies showing how the careful optimization of operational parameters enables them to overcome existing limitations. Therefore, the focus of this review was to highlight the potential of the synergy between MF and AM, emphasizing the significant benefits that this collaboration could entail. The combination of the techniques ensures the full customization of MF-based systems while remaining cost-effective and less time-consuming compared to classical approaches. Furthermore, MF and AM enable highly sustainable procedures suitable for industrial scale-out, leading to one of the most promising innovations of the near future.

1 March 2022 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
Federica SommonteFederica Sommonte
Federica Sommonte
IAIlaria Arduino
Ilaria Arduino
Giuseppe Francesco RacanielloGiuseppe Francesco Racaniello
Giuseppe Francesco Racaniello
ALAntonio Lopalco
Antonio Lopalco
ALAngela Assunta Lopedota
Angela Assunta Lopedota
Nunzio DenoraNunzio Denora
Nunzio Denora

16 November 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Federica SommonteFederica Sommonte
Federica Sommonte
Edward WeaverEdward Weaver
Edward Weaver
Essyrose MathewEssyrose Mathew
Essyrose Mathew
Nunzio DenoraNunzio Denora
Nunzio Denora
Dimitrios A. LamprouDimitrios A. Lamprou
Dimitrios A. Lamprou
Nanotechnology applications have emerged as one of the most actively researched areas in recent years. As a result, substantial study into nanoparticulate lipidic systems and liposomes (LPs) has been conducted. Regardless of the advantages, various challenges involving traditional manufacturing processes have hampered their expansion. Here, the combination of microfluidic technology (MF) and 3D printing (3DP) digital light processing (DLP) was fruitfully investigated in the creation of novel, previously unexplored “diamond shaped” devices suitable for the production of LPs carrying lysozyme as model drug. Computer-aided design (CAD) software was used designing several MF devices with significantly multiple and diverse geometries. These were printed using a high-performance DLP 3DP, resulting in extremely high-resolution chips that were tested to optimize the experimental condition of MF-based LPs. Monodisperse narrow-sized lysozyme-loaded PEGylated LPs were produced using in-house devices. The developed formulations succumbed to stability tests to determine their consistency, and then an encapsulation efficacy (EE) study was performed, yielding good findings. The in vitro release study indicated that lysozyme-loaded LPs could release up to 93% of the encapsulated cargo within 72 h. Therefore, the proficiency of the association between MF and 3DP was demonstrated, revealing a potential growing synergy.